[Value of a simultaneous association of several therapeutics in pemphigoid Duhring-Brocq disease. Apropos of 22 cases].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001151:Arsenic / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000473:pathology / Q000628:therapy*; D004357:Drug Synergism; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007116:Immunization, Passive; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000628:therapy*; D011278:Pregnanes / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D011278:Pregnanes; D013449:Sulfonamides; D000324:Adrenocorticotropic Hormone; D011736:Pyridoxine; D001151:Arsenic; D013831:Thiamine
Sur l'intérêt d'un association simultanée de plusieurs thérapeutiques dans la maladie de Duhring-Brocq pemphigoïde. A propos de 22 observations.